Cargando…

New progress in the study of germline susceptibility genes of myeloid neoplasms

In 2016, the World Health Organization incorporated ‘myeloid neoplasms with germline predisposition’ into its classification of tumors of hematopoietic and lymphoid tissues, revealing the important role of germline mutations in certain myeloid neoplasms, particularly myelodysplastic syndrome and acu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bi, Lei, Ma, Tianyuan, Li, Xu, Wei, Lai, Liu, Zinuo, Feng, Bingyue, Dong, Baoxia, Chen, Xiequn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933751/ https://www.ncbi.nlm.nih.gov/pubmed/33692849 http://dx.doi.org/10.3892/ol.2021.12578

Ejemplares similares

Molecular Pathogenesis in Myeloid Neoplasms with Germline Predisposition
por: Gao, Juehua, et al.
Publicado: (2021)

Familial Myelodysplastic/Acute Leukemia Syndromes—Myeloid Neoplasms with Germline Predisposition
por: Baptista, Renata Lyrio Rafael, et al.
Publicado: (2017)

Germline POT1 Variants Can Predispose to Myeloid and Lymphoid Neoplasms
por: Lim, Tristan L., et al.
Publicado: (2021)

DDX41-associated susceptibility to myeloid neoplasms
por: Makishima, Hideki, et al.
Publicado: (2023)

Germline and somatic JAK2 mutations and susceptibility to chronic myeloproliferative neoplasms
por: Goldin, Lynn R, et al.
Publicado: (2009)

Spectrum of myeloid neoplasms and immune deficiency associated with germline GATA2 mutations
por: Mir, Muhammad A, et al.
Publicado: (2015)

Clinical utility of targeted next‐generation sequencing for the diagnosis of myeloid neoplasms with germline predisposition
por: Andrés‐Zayas, Cristina, et al.
Publicado: (2021)

Next-Generation Sequencing of DDX41 in Myeloid Neoplasms Leads to Increased Detection of Germline Alterations
por: Bannon, Sarah A., et al.
Publicado: (2021)

Clinical and molecular correlates of somatic and germline DDX41 variants in patients and families with myeloid neoplasms
por: Badar, Talha, et al.
Publicado: (2023)

Systematic analysis of prognostic significance, functional enrichment and immune implication of STK10 in acute myeloid leukemia
por: Bi, Lei, et al.
Publicado: (2022)

Nordic Guidelines for Germline Predisposition to Myeloid Neoplasms in Adults: Recommendations for Genetic Diagnosis, Clinical Management and Follow-up
por: Baliakas, Panagiotis, et al.
Publicado: (2019)

Pegylated liposomal doxorubicin for myeloid neoplasms
por: Zhang, Cheng, et al.
Publicado: (2019)

The Genetic Landscape of Myelodysplastic Neoplasm Progression to Acute Myeloid Leukemia
por: Bănescu, Claudia, et al.
Publicado: (2023)

The inflammatory cytokine profile of myelodysplastic syndromes: A meta-analysis
por: Shi, Xin, et al.
Publicado: (2019)

Recurrent Germline Mutations of CHEK2 as a New Susceptibility Gene in Patients with Pheochromocytomas and Paragangliomas
por: Gao, Yinjie, et al.
Publicado: (2021)

P729: LANDSCAPE OF GERMLINE PATHOGENIC/ LIKELY PATHOGENIC MUTATIONS INVOLVING DNA REPAIR GENES IN SOLID TUMOR PATIENTS WITH ANTECEDENT OR SUBSEQUENT MYELOID NEOPLASMS
por: Hein, Kimberly, et al.
Publicado: (2023)

Co-occurrence of myeloid neoplasm and plasma cell neoplasm
por: Jum’ah, Husam, et al.
Publicado: (2022)

CD5-mediated inhibition of TCR signaling proceeds normally in the absence of SHP-1
por: DONG, BAOXIA, et al.
Publicado: (2016)

Prevalence of germline mutations in cancer susceptibility genes in Chinese patients with renal cell carcinoma
por: Feng, Huayi, et al.
Publicado: (2023)

Extracellular Vesicles in Myeloid Neoplasms
por: Karantanou, Christina, et al.
Publicado: (2022)

An integrated somatic and germline approach to aid interpretation of germline variants of uncertain significance in cancer susceptibility genes
por: Schwartz, Alison, et al.
Publicado: (2022)

New insights into aging-associated characteristics of female subcutaneous adipose tissue through integrative analysis of multi-omics data
por: Li, Zichao, et al.
Publicado: (2022)

Rare Germline Variants in Chordoma-Related Genes and Chordoma Susceptibility
por: Yepes, Sally, et al.
Publicado: (2021)

Germline breast cancer susceptibility genes, tumor characteristics, and survival
por: Ho, Peh Joo, et al.
Publicado: (2021)

Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9/SAMD9L syndromes
por: Sahoo, Sushree S., et al.
Publicado: (2020)

International Consensus Classification of myeloid and lymphoid neoplasms: myeloproliferative neoplasms
por: Gianelli, Umberto, et al.
Publicado: (2022)

Fanconi anemia gene variants in therapy-related myeloid neoplasms
por: Voso, M T, et al.
Publicado: (2015)

P506: CLINICAL VALIDATION OF THE NORDIC GUIDELINES FOR GERMLINE TESTING IN MYELOID NEOPLASMS: RESULTS FROM A MULTI-CENTER PROSPECTIVE COHORT STUDY
por: Tesi, Bianca, et al.
Publicado: (2023)

Germline breast cancer susceptibility gene mutations and breast cancer outcomes
por: Wang, Yong Alison, et al.
Publicado: (2018)

Myeloid Neoplasms in the Guise of Nutritional Deficiency
por: Parthasarathy, Veda
Publicado: (2012)

Bone marrow niches in myeloid neoplasms
por: Kitagawa, Masanobu, et al.
Publicado: (2019)

Editorial: Immunologic Mechanisms of Myeloid Neoplasms
por: Fattizzo, Bruno, et al.
Publicado: (2022)

From Clonal Hematopoiesis to Therapy-Related Myeloid Neoplasms: The Silent Way of Cancer Progression
por: Gurnari, Carmelo, et al.
Publicado: (2021)

Detection of Rare Germline Variants in the Genomes of Patients with B-Cell Neoplasms
por: Mosquera Orgueira, Adrián, et al.
Publicado: (2021)

Novel PRUNE2 Germline Mutations in Aggressive and Benign Parathyroid Neoplasms
por: Storvall, Sara, et al.
Publicado: (2023)

CHST15 gene germline mutation is associated with the development of familial myeloproliferative neoplasms and higher transformation risk
por: Chen, Yi, et al.
Publicado: (2022)

Synergistic Efficacy of the Demethylation Agent Decitabine in Combination With the Protease Inhibitor Bortezomib for Treating Multiple Myeloma Through the Wnt/β-Catenin Pathway
por: Jin, Yulong, et al.
Publicado: (2019)

Germline CEBPA mutation in familial acute myeloid leukemia
por: Boada, Matilde, et al.
Publicado: (2021)

Mutational mechanisms of EZH2 inactivation in myeloid neoplasms
por: Chase, Andrew, et al.
Publicado: (2020)

Prevalence and clinical implications of germline predisposition gene mutations in patients with acute myeloid leukemia
por: Kim, Borahm, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u9v7gjr381c95d2ajjb0ht1h26